RGEN
NASD Repligen Corporation$194.57 ↑ +0.00 (+0.00%) Trading Up from the previous close of $194.57, $2.08 below the day’s high of $196.65
- YTD change
- +18.74%
- vs 20-day SMA
- +10.50%
- vs 200-day SMA
- +36.07%
Price ranges
Price & Performance
+83.08 (+74.52%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 40.6% away from all-time highs of $327.32
- RGEN is up 19% since the beginning of the year
- RGEN is up 57% over the past 12 months
- RGEN is up 10% over the past 1 month
- 13% of all RGEN investors are betting against RGEN
RGEN reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +45.6%.
- Previous minute
- +$0.00
- Last hour
- +$2.67
- Last 5 days
- +7.67%
- vs 8-day SMA
- +5.07%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.